This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Sattar, N. Articles by Mathers, A. Search for Related Content PubMed PubMed Citation Articles by Sattar, N. Articles by Mathers, A. Pubmed/NCBI databases Substance via MeSH Medline Plus Health Information High Risk Pregnancy

Lipid and Lipoprotein Concentrations in Pregnancies Complicated by Intrauterine Growth Restriction¹

Departments of Pathological Biochemistry (N.S., P.J.G., C.J.P., J.S.), and Obstetrics and Gynaecology (I.A.G., T.K., A.M.), Royal Infirmary University NHS Trust, Glasgow G4 OSF, United Kingdom

Address all correspondence and requests for reprints to: Dr. Naveed Sattar, Department of Pathological Biochemistry, Macewen Building, Royal Infirmary NHS Trust, Glasgow G4 0SF, United Kingdom. E-mail: nsattar{at}clinmed.gla.ac.uk

Previous studies have shown that in preeclampsia, plasma lipids climb substantially above levels seen in normal pregnancies. Such lipid changes may play a role in the endothelial damage characteristic of preeclampsia. Pregnancies complicated by intrauterine growth restriction (IUGR), without preeclampsia, have similar placental pathology to preeclampsia despite the absence of the maternal systemic manifestations of hypertension and proteinuria. The aim of this study was to perform a cross-sectional study of lipid and lipoprotein concentrations in the third trimester, from normal pregnancies, and those complicated by IUGR without preeclampsia. Our hypothesis was that, in contrast to the exaggerated lipid changes seen in preeclampsia, lipid and lipoprotein concentrations in IUGR would be similar to those of matched healthy pregnant controls. Fasting blood samples for lipids and lipoprotein fractions were taken in the third trimester, from eight women with IUGR; and eight women with uncomplicated pregnancies, matched as a group for age, booking weight, parity, and gestational age at sampling. There were no significant differences (P > 0.05) in the median concentrations of triglyceride, high-density lipoprotein, and very-low-density lipoprotein 1 (VLDL₁), between cases and controls. However, women with IUGR pregnancies had significantly lower cholesterol [4.95 mmol/L (3.35–7.10) vs. 7.47 (5.75–8.45); median (range) for IUGR patients and controls, respectively; P < 0.01], low-density lipoprotein (LDL)-cholesterol [2.45 mmol/L (0.95–3.60) vs. 4.25 (3.35–5.60); P < 0.01], VLDL₂ mass [59.0 mg/dL (37–87) vs. 103.0 (64–168); P < 0.01], intermediate-density lipoprotein mass [56.0 mg/dL (31–110) vs. 125.6 (91–157); P < 0.01], and total LDL mass [221.0 mg/dL (104–237) vs. 380.3 (267–534); P < 0.01]. In addition, it was noteworthy that, with respect to LDL-cholesterol and total LDL mass, there was little or no overlap in the ranges of concentrations measured between cases and controls. Because VLDL₂ and intermediate-density lipoprotein are the synthetic precursors to LDL in the circulation, their significantly lower median concentrations imply a failure of appropriate LDL synthesis in IUGR pregnancies. Whatever the mechanism, if our results are confirmed in larger studies and longitudinal investigations, then LDL-cholesterol measurements (when LDL-cholesterol fails to rise appropriately or is low in the third trimester) may be of use in identifying mothers with, or at risk of, a pregnancy complicated by IUGR.

This article has been cited by other articles:

				R. B. Ness, J. Zhang, D. Bass, and M. A. Klebanoff Interactions between Smoking and Weight in Pregnancies Complicated by Preeclampsia and Small-for-Gestational-Age Birth Am. J. Epidemiol., June 16, 2008; (2008) kwn140v1. [Abstract] [Full Text] [PDF]

				P. R. Romundstad, G. D. Smith, T. I. L. Nilsen, and L. J. Vatten Associations of Prepregnancy Cardiovascular Risk Factors with the Offspring's Birth Weight Am. J. Epidemiol., December 15, 2007; 166(12): 1359 - 1364. [Abstract] [Full Text] [PDF]

				R. J. Edison, K. Berg, A. Remaley, R. Kelley, C. Rotimi, R. E. Stevenson, and M. Muenke Adverse Birth Outcome Among Mothers With Low Serum Cholesterol Pediatrics, October 1, 2007; 120(4): 723 - 733. [Abstract] [Full Text] [PDF]

				C. Wadsack, S. Tabano, A. Maier, U. Hiden, G. Alvino, V. Cozzi, M. Huttinger, W. J. Schneider, U. Lang, I. Cetin, et al. Intrauterine growth restriction is associated with alterations in placental lipoprotein receptors and maternal lipoprotein composition Am J Physiol Endocrinol Metab, February 1, 2007; 292(2): E476 - E484. [Abstract] [Full Text] [PDF]

				A. L. Magnusson, I. J. Waterman, M. Wennergren, T. Jansson, and T. L. Powell Triglyceride Hydrolase Activities and Expression of Fatty Acid Binding Proteins in the Human Placenta in Pregnancies Complicated by Intrauterine Growth Restriction and Diabetes J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4607 - 4614. [Abstract] [Full Text] [PDF]

				K. Winkler, B. Wetzka, M. M. Hoffmann, I. Friedrich, M. Kinner, M. W. Baumstark, H. Wieland, W. März, and H. P. Zahradnik Low Density Lipoprotein (LDL) Subfractions during Pregnancy: Accumulation of Buoyant LDL with Advancing Gestation J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4543 - 4550. [Abstract] [Full Text]